Week 11 - Progesterones Flashcards
Role of progesterone in the body
- Thins and stabilizes endometrium
- Thickens cervical mucous
- Relaxes smooth muscle of uterus
- Thins vaginal mucosa
Progesterone: MOA
- Thickening of cervical mucus to inhibit sperm migration
- Suppresses ovulation
- Lowers mid-cycle peak of FSH and LH
- Slows egg movement through fallopian tube
- Thins endometrium
Progestin-only therapy examples
- Etonogestrel implant (Nexplanon)
- Levonorgestrel-releasing intrauterine devices (IUDs; Mirena, Skyla)
- Depot medroxyprogesterone (DMPA) injection (Depo-Provera)
Overall complication rates are LOW for all progestin-only methods
True/False: Progestin-only-pill doses are higher than doses in combined oral contraceptive (COCs)
False - doses are LOWER
Progestin-only-pills: norethindrone (Camila)
Administered continuously
Does not consistently suppress ovulation; approximately half of women ovulate
Progestin-only-pills: drospirenone (Slynd)
24 active and 4 inert tablets
Suppresses ovulation; antimineralcorticoid activity
Progesterone in contraception: cautions
- If patient has acne, lower dose progesterone with less androgen effect
- Overall effect of all COCs is anti-androgenic regardless of type of progestin
Names of progestin contraceptive pills with HIGH levels of activity
- Norgestrel
- Levonorgestrel
Progesterone in contraception: ADR
- Irregular breakthrough bleeding
- Breast tenderness
- Galactorrhea
- Nausea
- Weight gain
- Osteoporosis risk with 2+ year use
Progesterone in contraception: contraindications
- Known or suspected pregnancy
- Known or suspected breast cancer
- Undiagnosed abnormal uterine bleeding
- Benign or malignant liver tumors, cirrhosis, acute liver disease
- Thromboembolic disease
- Breast cancer
- Depression
Combined oral contraceptives: drug interactions
- Metabolism increased by any drug that increases liver microsomal enzyme activity
- Efficacy diminished if concurrently taking a drug with this effect
- Anticonvulsants
- Gabapentin, levetiracetam, valproate, zonisamide DO NOT appear to reduce efficacy
- Rifampin is the ONLY abx that reduces serum ethinyl estradiol and progestin levels
Progesterone in menopause: indications
- Add progestin to MHT for women w/ uterus
- Prevents uterine hyperplasia
- NOT indicated in women who have undergone hysterectomy
- NOT indicated in low-risk women on low dose vaginal estrogen
Progesterone in menopause: medroxyprogesterone acetate (MPA)
- Prevents endometrial hyperplasia
- Associated with increase risk of breast cancer, possibly coronary heart disease, and unfavorable effect on lipids
Progesterone in menopause: micronized progesterone
- First line
- Bioidentical, commonly prescribed
- Protects endometrium
- Minimal negative effect on lipids
- No apparent increase to risk of breast cancer or coronary heart disease
Menopause hormone therapy (MHT)
- Cyclic regimen
- Natural progesterone (prometrium)
- Days 1-14 of each calendar month
- Given w/ continuous daily estrogen
- Majority of women have monthly withdrawal bleeding